External validation of non-invasive predictors of hepatocellular carcinoma in patients with HCV-related advanced chronic liver disease after oral antivirals

Prediction models or scores for hepatocellular carcinoma (HCC) risk stratification are needed to guide individualized management of patients with HCV-related cirrhosis, who are increasingly being treated with highly effective and safe direct-acting antivirals (DAAs).1,2

Source: Journal of Hepatology - June 2, 2020 Category: Gastroenterology Authors: Gamal Shiha Tags: Letter to the Editor Source Type: research